Targeting lactate metabolism in B cells presents a potential strategy to reduce inflammation and senescence, thereby mitigating immune dysfunction in cancer.213,214 Furthermore, inhibiting PDK4 redirects cellular metabolism toward mitochondrial oxidative phosphorylation, curbing SASP-associated cytokine production and enhancing the sensitivity of senescent cells to apoptosis-inducing agents. This evidence concerns the gene PDK4 and cancer.